Lacticaseibacillus casei CNCM I-5663 supplementation maintained muscle mass in a model of frail rodents
- 1INRAE, UMR 1019, Unité de Nutrition Humaine, Université Clermont Auvergne, Clermont-Ferrand, France
- 2Université Paris-Saclay, INRAE UMR 1319, AgroParisTech, Micalis Institute, Jouy-en-Josas, France
- 3INRAE UMR 0545, Unité Mixte de Recherche sur le Fromage, Université Clermont Auvergne, VetAgro Sup, Aurillac, France
A corrigendum on
Lacticaseibacillus casei CNCM I-5663 supplementation maintained muscle mass in a model of frail rodents
by Giron, M., Thomas, M., Jarzaguet, M., Mayeur, C., Ferrere, G., Noordine, M.-L., Bornes, S., Dardevet, D., Chassard, C., and Savary-Auzeloux, I. (2022). Front. Nutr. 9:928798. doi: 10.3389/fnut.2022.928798
In the published article, there was an error in the legend for Figure 6A as published. The title on Y-axis is “Protein content in hindlimb muscle (mg/g).” The corrected legend appears below.
Figure 6. Levels of protein, insulin pathway mediators, and proteolysis-related gene expression in the muscles of 18-month-old rats fed an ad libitum (AL) diet or a food-restricted (R) diet over a one-month period; one food-restricted group received a probiotic supplement – strain 63 (R+63). (A) Protein levels in hindlimb muscles (gastrocnemius, soleus, tibialis anterior, and extensor digitorum longus). (B) Levels of proteins involved in the AKT/mTOR/S6K pathway: ratio of phosphorylated proteins, p-S6 (Ser235/236), and p-eIF2α (Ser51), to total proteins, S6 and eIF2α. (C) Expression levels of muscle proteolysis genes, namely those related to the regulation of the ubiquitin-proteasome-dependent pathway (Atrogin-1 and MuRF-1) and autophagy pathway (Lc3b, ATG16L, and Cathepsin L). Values are means ± SEM. Differences in letters indicate a significant difference between groups (Kruskal–Wallis test and Dunn's post hoc test, p ≤ 0.05, n = 61 rats).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: muscle, sarcopenia, probiotic, lactic acid bacteria, insulin sensitivity, protein synthesis
Citation: Giron M, Thomas M, Jarzaguet M, Mayeur C, Ferrere G, Noordine M-L, Bornes S, Dardevet D, Chassard C and Savary-Auzeloux I (2023) Corrigendum: Lacticaseibacillus casei CNCM I-5663 supplementation maintained muscle mass in a model of frail rodents. Front. Nutr. 9:1109835. doi: 10.3389/fnut.2022.1109835
Received: 28 November 2022; Accepted: 29 November 2022;
Published: 04 January 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Giron, Thomas, Jarzaguet, Mayeur, Ferrere, Noordine, Bornes, Dardevet, Chassard and Savary-Auzeloux. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Isabelle Savary-Auzeloux, aXNhYmVsbGUuc2F2YXJ5LWF1emVsb3V4JiN4MDAwNDA7aW5yYWUuZnI=